Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems.
Wang
R Y
RY
Department of Psychiatry and Behavioral Science, State University of New York, Stony Brook 11794.
D000818:Animals; D002766:Cholecystokinin / Q000502:physiology*; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D004594:Electrophysiology; D006801:Humans; D008636:Mesencephalon / Q000503:physiopathology; D008954:Models, Biological; D009714:Nucleus Accumbens / Q000187:drug effects / Q000503:physiopathology; D051381:Rats; D012559:Schizophrenia / Q000503:physiopathology*; D012844:Sincalide / Q000494:pharmacology; D013569:Synapses / Q000502:physiology
D002766:Cholecystokinin; D012844:Sincalide; D004298:Dopamine